Sonnet biotherapeutics announces adjournment of annual meeting due to lack of quorum

Princeton, nj / accesswire / june 2, 2022 / sonnet biotherapeutics holdings, inc. (nasdaq:sonn) ("sonnet" or the "company"), a biopharmaceutical company developing innovative targeted biologic drugs, today announced that the company's 2022 annual meeting of stockholders, on june 2, 2022 at 9:00 a.m. eastern time, was convened and adjourned, without any business being conducted, due to lack of the required quorum.
SONN Ratings Summary
SONN Quant Ranking